Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 89,078 | 97,661 | 115,509 | 25,617 | 29,111 |
| Marketable Securities | N/A | 9,986 | 19,803 | N/A | 74,187 |
| Other current assets | 0 | 0 | 0 | 0 | 314 |
| TOTAL | $93,898 | $111,620 | $138,043 | $28,716 | $106,635 |
| Non-Current Assets | |||||
| PPE Net | 1,488 | 1,553 | 1,659 | 1,782 | 0 |
| Investments And Advances | 2,600 | 3,275 | 4,724 | 0 | 13,957 |
| Other Non-Current Assets | 6,556 | 7,759 | 7,908 | 16,559 | 19,471 |
| TOTAL | $10,644 | $12,587 | $14,291 | $18,341 | $33,428 |
| Total Assets | $104,542 | $124,207 | $152,334 | $47,057 | $140,063 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,533 | N/A | 3,088 | 878 | N/A |
| Accounts payable and accrued liabilities | 1,258 | 2,484 | 4,960 | 3,468 | 7,803 |
| Accrued Expenses | 8,912 | 11,020 | 19,825 | 9,763 | 15,711 |
| Other current liabilities | 2,680 | 3,690 | 5,080 | N/A | N/A |
| TOTAL | $14,383 | $17,194 | $32,953 | $14,109 | $25,292 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,071 | 12,554 | 9,400 | 4,581 | N/A |
| Other Non-Current Liabilities | 60,793 | 60,948 | 61,212 | 99,843 | 26,560 |
| TOTAL | $71,864 | $73,502 | $70,612 | $104,424 | $26,560 |
| Total Liabilities | $86,247 | $90,696 | $103,565 | $118,533 | $51,852 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,181 | 12,060 | 11,942 | 663 | 3,221 |
| Common Shares | 2 | 2 | 2 | 1 | 6 |
| Retained earnings | -220,625 | -203,030 | -186,052 | -187,081 | -525,979 |
| Other shareholders' equity | -1 | -1 | -5 | 111,445 | -36 |
| TOTAL | $18,295 | $33,511 | $48,769 | $-71,476 | $88,211 |
| Total Liabilities And Equity | $104,542 | $124,207 | $152,334 | $47,057 | $140,063 |